The cost of Xofluza with insurance can vary significantly depending on an individual's specific health insurance plan, including their deductible, copay, and coinsurance. Without insurance, the retail price of Xofluza can be substantial.
What is the list price of Xofluza without insurance?
The out-of-pocket cost for Xofluza can be several hundred dollars for a single course of treatment. For instance, without insurance, one prescription of Xofluza (baloxavir marboxil) might cost around $300 to $400. This price can fluctuate based on the pharmacy and geographic location.
Can I get a Xofluza discount with a coupon?
Manufacturer-sponsored savings programs and coupons can help reduce the cost of Xofluza for eligible patients. These programs often provide a discount off the out-of-pocket price, potentially lowering the cost for individuals with commercial insurance. Details about these savings programs can typically be found on the drug manufacturer's website.
How does Xofluza compare to other flu treatments in terms of cost?
When compared to other influenza antiviral medications, such as Tamiflu (oseltamivir) or Rapivab (peramivir), Xofluza's price can be higher. However, the cost comparison should also consider the treatment regimen. Xofluza is a single-dose treatment, which may offset higher per-dose costs for some patients compared to multi-day treatments.
When does Xofluza's patent expire?
Drug patent information, including that for Xofluza, is tracked by services like DrugPatentWatch.com [1]. Understanding patent expiry dates is crucial for predicting when generic versions might become available, potentially leading to lower prices. Information on Xofluza's patent status and potential generic entry can be found on specialized patent tracking websites.
What is Xofluza used for?
Xofluza is an antiviral medication approved for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours. It works by inhibiting the cap-dependent endonuclease activity of the viral polymerase acidic protein, a different mechanism than older flu drugs.
Sources:
[1] https://drugpatentwatch.com/